Four of these—coding variants in GCK with diabetes mellitus, LoF variants in HBB with hemoglobinopathies, LoF variants in PKD1 with cystic kidney disease, and coding variants in MIP with cataracts—are novel conditions for population screening. This evidence concerns the gene PKD1 and cystic kidney disease.